AI assistant
Rua Bioscience Limited — Capital/Financing Update 2025
Nov 2, 2025
66262_rns_2025-11-03_d5a4fae4-c29b-4f38-a2b7-057988ccbc00.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [101 x 28] intentionally omitted <==
QUOTATION NOTICE: NZX MAIN BOARD RUA BIOSCIENCE LIMITED (“RUARB”) RIGHTS
Issuer: Rua Bioscience Limited (“RUA”) Ticker Code: RUARB ISIN: NZRUAE0006S6 Details of Issue: A pro-rata renounceable rights issue of 1 new share for every 3 existing shares held on the Record Date. Ratio (New: Existing): 1 : 3 Exercise Price: NZ$0.025 per new share Reference Price: Calculated as head share price prior to quotation minus the Exercise Price Issue Price Payable: In full on application Registrar: Computershare Investor Services Limited (“RMLT”) Settlement Status: NZCDC Settlement System Key Dates Ex Rights Date: Friday, 7 November 2025 Rights Commence Trading: Friday, 7 November 2025 Record Date: 5pm, Monday, 10 November 2025 Letters of Entitlement sent to Tuesday, 11 November 2025 Shareholders: Offer Opens: Tuesday, 11 November 2025 Rights Quotation Ceases: Monday, 24 November 2025 Offer Closes: Friday, 28 November 2025 Allotment and commencement of Thursday, 4 December 2025 trading of New Shares (retail offer):
==> picture [137 x 65] intentionally omitted <==
Mark Peterson Chief Executive Officer NZX Limited
3 November 2025